We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Commission (EC) reclassified hip, knee and shoulder joint replacements so they will require a higher level of scrutiny by certification organizations before entering the market, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) announced.
Boston Scientific said in a recent SEC filing that it is facing numerous lawsuits, including more than 1,000 cases related to its acquisition of heart-device maker Guidant and a series of patent infringement cases with rival devicemakers.
U.S. Medical's recently approved EndoSurgical operating system has been used in two surgical procedures in the U.S. for the first time, the company announced.
The reprocessed device market is expected to reach $200 million by 2011 -- a $70 million increase over its 2006 value -- according to an analysis by Millennium Research Group (MRG).
Philips Medical Systems is continuing discussions with the FDA over the company's alleged deviations from current good manufacturing practices related to the production of its automated external defibrillators (AEDs), the firm said.
A new Medicare initiative will drive an increase in abdominal aortic aneurysm (AAA) procedures, prompting stent graft market growth of 13 percent per year over the next five years, according to a report by Millennium Research Group (MRG).
A major study of carotid stenting has reproduced results of a previous large study, showing the treatment is safe and effective for preventing stroke in high-risk patients, the Society of Interventional Radiology announced.